HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$10.59
Day range
$10.40 - $10.77
Year range
$4.93 - $20.80
Market cap
404.74M USD
Avg Volume
256.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.61M | -91.75% |
Operating expense | 10.30M | 3.34% |
Net income | -44.13M | -214.52% |
Net profit margin | -2.73K | -3,713.74% |
Earnings per share | -1.06 | -202.86% |
EBITDA | -45.82M | -121.13% |
Effective tax rate | -1.50% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 326.84M | -27.26% |
Total assets | 412.90M | -25.55% |
Total liabilities | 72.18M | -45.38% |
Total equity | 340.72M | — |
Shares outstanding | 35.86M | — |
Price to book | 1.11 | — |
Return on assets | -27.30% | — |
Return on capital | -28.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -44.13M | -214.52% |
Cash from operations | -28.31M | -16.68% |
Cash from investing | 49.11M | 159.22% |
Cash from financing | 8.00K | 172.73% |
Net change in cash | 20.80M | 119.41% |
Free cash flow | -13.85M | 26.95% |
About
Founded
2016
Headquarters
Website
Employees
183
